LGVN
NASDAQ
$0.60
Longeveron Inc - Class A (LGVN)
Longeveron Inc., a clinical-stage biotechnology company, is dedicated to developing cell therapies for life-threatening and aging-related conditions. The company is headquartered in Miami, Florida.
Sector:
Healthcare
Industry:
Biotechnology
Target: $7.15 (+1087.31%)
Market Cap
$16M
FCF 5Y CAGR
+29.97%
Beta (5Y)
1.07
Price Chart
Valuation
Market Cap$16M
P/S16.51
P/B1.23
Profitability
Total Revenue (TTM)$1.22M
Gross Profit (TTM)$792K
EBITDA-$21M
Operating Margin-1149%
EPS-$1.16
Financial Health
Debt-to-Equity4.7%
Growth & Risk
EPS 5Y CAGR-21.63%
Revenue 5Y CAGR-22.31%
FCF 5Y CAGR+29.97%
Beta (5Y)1.07
Sharpe Ratio-0.30